Original Research

Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention

Li L, Ge Z, Zhang D, Kuang J, Ma X, Jiang S

Drug Design, Development and Therapy 2017, 11:3299-3307

Published Date: 21 November 2017